InspireMD (NSPR) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts NSPR Hot Sheet
Join SI Premium – FREE
InspireMD (NASDAQ: NSPR) reported Q4 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.15 million versus the consensus estimate of $2.32 million.
For earnings history and earnings-related data on InspireMD (NSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Allwyn AG (ALWN:GA) at Neutral
- JPMorgan Starts BridgeBio Oncology Therapeutics, In (BBOT) at Overweight
- JPMorgan Starts J&T Global Express (1519:HK) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
